![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CHPF2 |
Gene summary for CHPF2 |
![]() |
Gene information | Species | Human | Gene symbol | CHPF2 | Gene ID | 54480 |
Gene name | chondroitin polymerizing factor 2 | |
Gene Alias | CSGLCA-T | |
Cytomap | 7q36.1 | |
Gene Type | protein-coding | GO ID | GO:0006022 | UniProtAcc | B3KPG6 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
54480 | CHPF2 | LZE7T | Human | Esophagus | ESCC | 1.81e-02 | 2.30e-01 | 0.0667 |
54480 | CHPF2 | LZE20T | Human | Esophagus | ESCC | 1.06e-03 | 1.32e-01 | 0.0662 |
54480 | CHPF2 | LZE24T | Human | Esophagus | ESCC | 1.35e-04 | 1.10e-01 | 0.0596 |
54480 | CHPF2 | P1T-E | Human | Esophagus | ESCC | 1.72e-02 | 1.50e-01 | 0.0875 |
54480 | CHPF2 | P2T-E | Human | Esophagus | ESCC | 7.63e-08 | 8.96e-02 | 0.1177 |
54480 | CHPF2 | P4T-E | Human | Esophagus | ESCC | 2.10e-03 | 1.03e-01 | 0.1323 |
54480 | CHPF2 | P5T-E | Human | Esophagus | ESCC | 3.42e-04 | 4.96e-02 | 0.1327 |
54480 | CHPF2 | P8T-E | Human | Esophagus | ESCC | 3.80e-12 | 1.76e-01 | 0.0889 |
54480 | CHPF2 | P9T-E | Human | Esophagus | ESCC | 1.01e-07 | 1.54e-01 | 0.1131 |
54480 | CHPF2 | P10T-E | Human | Esophagus | ESCC | 3.87e-11 | 1.84e-01 | 0.116 |
54480 | CHPF2 | P11T-E | Human | Esophagus | ESCC | 7.61e-05 | 3.48e-01 | 0.1426 |
54480 | CHPF2 | P12T-E | Human | Esophagus | ESCC | 1.01e-12 | 2.41e-01 | 0.1122 |
54480 | CHPF2 | P15T-E | Human | Esophagus | ESCC | 1.20e-20 | 4.41e-01 | 0.1149 |
54480 | CHPF2 | P16T-E | Human | Esophagus | ESCC | 2.15e-10 | 1.17e-01 | 0.1153 |
54480 | CHPF2 | P19T-E | Human | Esophagus | ESCC | 9.63e-05 | 4.91e-01 | 0.1662 |
54480 | CHPF2 | P20T-E | Human | Esophagus | ESCC | 2.05e-03 | 3.43e-02 | 0.1124 |
54480 | CHPF2 | P21T-E | Human | Esophagus | ESCC | 4.01e-16 | 2.52e-01 | 0.1617 |
54480 | CHPF2 | P22T-E | Human | Esophagus | ESCC | 2.69e-04 | 5.69e-02 | 0.1236 |
54480 | CHPF2 | P24T-E | Human | Esophagus | ESCC | 1.77e-10 | 1.22e-01 | 0.1287 |
54480 | CHPF2 | P26T-E | Human | Esophagus | ESCC | 4.60e-05 | 1.24e-01 | 0.1276 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00091002 | Esophagus | ESCC | glycoprotein metabolic process | 226/8552 | 387/18723 | 2.64e-07 | 3.94e-06 | 226 |
GO:00067906 | Esophagus | ESCC | sulfur compound metabolic process | 201/8552 | 339/18723 | 2.64e-07 | 3.94e-06 | 201 |
GO:00442725 | Esophagus | ESCC | sulfur compound biosynthetic process | 96/8552 | 148/18723 | 1.86e-06 | 2.16e-05 | 96 |
GO:00091012 | Esophagus | ESCC | glycoprotein biosynthetic process | 181/8552 | 317/18723 | 2.54e-05 | 2.15e-04 | 181 |
GO:0006029 | Esophagus | ESCC | proteoglycan metabolic process | 48/8552 | 79/18723 | 4.93e-03 | 1.89e-02 | 48 |
GO:0030166 | Esophagus | ESCC | proteoglycan biosynthetic process | 35/8552 | 56/18723 | 8.30e-03 | 2.94e-02 | 35 |
GO:0006024 | Esophagus | ESCC | glycosaminoglycan biosynthetic process | 45/8552 | 75/18723 | 8.75e-03 | 3.08e-02 | 45 |
GO:0006023 | Esophagus | ESCC | aminoglycan biosynthetic process | 47/8552 | 79/18723 | 9.29e-03 | 3.23e-02 | 47 |
GO:000679021 | Liver | HCC | sulfur compound metabolic process | 212/7958 | 339/18723 | 5.60e-14 | 3.39e-12 | 212 |
GO:00442722 | Liver | HCC | sulfur compound biosynthetic process | 95/7958 | 148/18723 | 7.89e-08 | 1.58e-06 | 95 |
GO:0009100 | Liver | HCC | glycoprotein metabolic process | 193/7958 | 387/18723 | 1.89e-03 | 9.62e-03 | 193 |
GO:00442724 | Oral cavity | OSCC | sulfur compound biosynthetic process | 82/7305 | 148/18723 | 3.71e-05 | 3.31e-04 | 82 |
GO:00067905 | Oral cavity | OSCC | sulfur compound metabolic process | 168/7305 | 339/18723 | 4.50e-05 | 3.84e-04 | 168 |
GO:0030206 | Oral cavity | OSCC | chondroitin sulfate biosynthetic process | 15/7305 | 18/18723 | 1.53e-04 | 1.07e-03 | 15 |
GO:00091001 | Oral cavity | OSCC | glycoprotein metabolic process | 185/7305 | 387/18723 | 2.37e-04 | 1.54e-03 | 185 |
GO:00091011 | Oral cavity | OSCC | glycoprotein biosynthetic process | 151/7305 | 317/18723 | 1.01e-03 | 5.26e-03 | 151 |
GO:0050650 | Oral cavity | OSCC | chondroitin sulfate proteoglycan biosynthetic process | 16/7305 | 23/18723 | 2.93e-03 | 1.27e-02 | 16 |
GO:0030204 | Oral cavity | OSCC | chondroitin sulfate metabolic process | 19/7305 | 30/18723 | 6.03e-03 | 2.28e-02 | 19 |
GO:000679012 | Oral cavity | LP | sulfur compound metabolic process | 106/4623 | 339/18723 | 3.36e-03 | 2.25e-02 | 106 |
GO:00442726 | Thyroid | PTC | sulfur compound biosynthetic process | 63/5968 | 148/18723 | 3.91e-03 | 1.87e-02 | 63 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa00532 | Oral cavity | OSCC | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 16/3704 | 21/8465 | 2.61e-03 | 6.77e-03 | 3.45e-03 | 16 |
hsa005321 | Oral cavity | OSCC | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 16/3704 | 21/8465 | 2.61e-03 | 6.77e-03 | 3.45e-03 | 16 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CHPF2 | SNV | Missense_Mutation | c.1370G>C | p.Gly457Ala | p.G457A | Q9P2E5 | protein_coding | deleterious(0) | possibly_damaging(0.884) | TCGA-CG-4437-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
CHPF2 | SNV | Missense_Mutation | c.397T>C | p.Tyr133His | p.Y133H | Q9P2E5 | protein_coding | deleterious(0) | possibly_damaging(0.825) | TCGA-CG-5726-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
CHPF2 | SNV | Missense_Mutation | rs199940789 | c.808N>A | p.Gly270Ser | p.G270S | Q9P2E5 | protein_coding | tolerated(1) | benign(0.039) | TCGA-HU-8602-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Chemotherapy | xeloda | CR |
CHPF2 | SNV | Missense_Mutation | rs138308089 | c.2237N>A | p.Arg746His | p.R746H | Q9P2E5 | protein_coding | tolerated(0.43) | possibly_damaging(0.891) | TCGA-VQ-A8P2-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unspecific | Complete Response | |
CHPF2 | deletion | Frame_Shift_Del | c.413delN | p.Ala140ProfsTer68 | p.A140Pfs*68 | Q9P2E5 | protein_coding | TCGA-BR-6852-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |||
CHPF2 | insertion | Frame_Shift_Ins | rs777152284 | c.1934_1935insC | p.Ser648LeufsTer6 | p.S648Lfs*6 | Q9P2E5 | protein_coding | TCGA-HU-A4GQ-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | ||
CHPF2 | insertion | Frame_Shift_Ins | rs777152284 | c.1934_1935insC | p.Ser648LeufsTer6 | p.S648Lfs*6 | Q9P2E5 | protein_coding | TCGA-HU-A4GT-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | copolang | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |